Stock EUROFINS-CEREP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Eurofins-Cerep Stock Euronext Paris

Equities

FR0012413771

Biotechnology & Medical Research

Financials

Sales 2021 41.63M 44.64M Sales 2022 47.65M 51.09M Capitalization 112M 120M
Net income 2021 9M 9.65M Net income 2022 11M 11.8M EV / Sales 2021 2.05 x
Net cash position 2021 1.28M 1.37M Net cash position 2022 12.81M 13.73M EV / Sales 2022 2.08 x
P/E ratio 2021 *
-
P/E ratio 2022
-
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 4.22%
More Fundamentals * Assessed data

Chart Eurofins-Cerep

Dynamic Chart

Latest news about Eurofins-Cerep

Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Global markets live: Daimler, GSK, Mattel Our Logo
Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain MT
Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Eurofins Cerep SA acquired KVI-Plusz. CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A. CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, agreed to acquire majority stake in Bioaccess S.A. for €225 million. CI
Eurofins-Panlabs, Inc. completed the acquisition of Cerep Inc. from Cerep SA. CI
Eurofins-Panlabs, Inc. agreed to acquire Cerep Inc. from Cerep SA for $0.27 million. CI
Eurofins Discovery Services Lux Holding completed the acquisition of 8.48% stake in Cerep SA from Thierry Jean. CI
Eurofins Scientific SA completed the acquisition of 75.13% stake in Cerep SA for €18.9 million. CI
Eurofins Scientific SA made an offer to acquire remaining 91.52% stake in Cerep SA for €23.1 million. CI
Eurofins Discovery Services Lux Holding agreed to acquire 8.48% stake in Cerep SA from Thierry Jean for €2.1 million. CI
More news

Press releases Eurofins-Cerep

Eurofins Cerep : annonce ses résultats 2022 PU
More press releases

News in other languages on Eurofins-Cerep

Le bric-à-brac de Zonebourse : Tuto pour le FedWatch, actions ultra-chères et Carmat
Plus c'est long, moins c'est bon
En Direct des Marchés : Carrefour, Engie, Unibail, Casino, Valneva, Delivery Hero, Fedex, Bayer...
Lo sapevi? Société des Chemins de Fer et Tramways du Var et du Gard
Le saviez-vous ? Société des Chemins de Fer et Tramways du Var et du Gard
More news

Managers and Directors - Eurofins-Cerep

Managers TitleAgeSince
Antoine Duthilleul CEO
 Chief Executive Officer - 18-04-18
Damien Séroux CHM
 Chairman - 14-10-12
Members of the board TitleAgeSince
Damien Séroux CHM
 Chairman - 14-10-12
Christina Shasserre BRD
 Director/Board Member 68 15-06-09
Antoine Duthilleul CEO
 Chief Executive Officer - 18-04-18
More insiders

Company Profile

Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry. Exports account for 97.9% of net sales.
Sector
Biotechnology & Medical Research
Calendar
2024-05-22 - Shareholders Meeting
More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.12% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+6.77% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+45.26% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-11.96% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.01% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.92% 18.17B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.63% 11.7B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.16% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.30% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALECR Stock
  4. Stock